Early Phase Pain Investigation Clinical Network Hub at the University of Washington
Early Phase Pain Investigation Clinical Network Hub at the University of Washington
批准号:
10903640
负责人:
Michele Curatolo
金额:
$11.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-30 至 2024-08-31
关键词:
AffectAlaskaAmbulatory CareAnalgesicsBehavioralBioethicsBiological MarkersCaringChildhoodClinicalClinical ResearchClinical TrialsClinical and Translational Science AwardsCollaborationsCommunicationConduct Clinical TrialsConsultationsDataDevelopmentDimensionsDiseaseElderlyEpidemicFamily PracticeGeographyGoalsHealthHelping to End Addiction Long-termIdahoIllinoisInfrastructureInpatientsLaboratoriesLeadershipMedicalMedical centerMedicineMilitary PersonnelMonitorMontanaMulti-Institutional Clinical TrialOperative Surgical ProceduresOregonOutpatientsPacific NorthwestPainPain ClinicsPain DisorderPain managementParticipantPatient RecruitmentsPatientsPediatric HospitalsPerformancePhasePhase II Clinical TrialsPhenotypePoliciesPopulationPrincipal InvestigatorProceduresPublic HealthRecording of previous eventsResearchResearch PersonnelResearch SupportResourcesRural PopulationSafetyScienceSensorySiteTestingTrainingTraining and EducationTranslational ResearchUnderserved PopulationUniversitiesWashingtonWorkWritingWyomingbiomarker validationbiopsychosocialcancer careclinical biomarkersclinical centerclinical investigationclinical research siteclinically significantdesignexperienceflexibilityinnovationmedical specialtiesmultidisciplinaryneuroimagingopioid epidemicopioid misuseoverdose deathparticipant enrollmentpatient populationphase II trialpsychologicquality assurancerecruitresponseskillstranslational health sciencevalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The concurrent public health crises of opioid misuse with associated overdose death epidemic and inadequate
options for pain management require innovative, far-reaching, safe and effective solutions. The University of
Washington’s (UW) Division of Pain Medicine (UW Pain) is a Specialized Clinical Center within EPPIC-Net,
representing the Pacific Northwest region and beyond. UW Pain (“hub”) includes four core clinical sites: UW
Medical Center, Harborview Medical Center, Seattle Children’s Hospital, and Seattle Cancer Care Alliance. The
hub is driven by an experienced core team that has leveraged existing infrastructure and resources and
identified a flexible, diverse, and robust network of spoke sites to help meet the broad needs of EPPIC-Net.
Our team of principal investigators has extensive relevant experience in conducting multi-site clinical trials
across all phases and in deep phenotyping, such as behavioral and psychological profiling, quantitative
sensory testing, neuroimaging, and biomarker research. The team is further supported by research
coordinators and will work closely with UW’s Institute for Translational Health Sciences (ITHS), the site of UW’s
Clinical and Translational Science Award. Relevant UW departments affords access to disease-specific
expertise and patient populations. Our network spans multiple states and specialties, allowing access to
geographically and demographically diverse (including underrepresented and underserved) patient populations
and a broad range of medical and surgical disorders for which pain is a clinically significant component. To
achieve the goals of the HEAL initiative’s EPPIC-Net, we have: (1) Established UW EPPIC-Net Hub and
Spokes infrastructure, provide scientific leadership and administrative oversight, and apply our expertise in
design and conduct of high-quality multidisciplinary Phase 2 clinical trials and biomarker validation studies; (2)
Developed policies and procedures for rapid design, initiation, recruitment, conduct, and closure of high quality
multidisciplinary Phase 2 clinical trials and biomarker validation studies for specific pain conditions at UW Pain
EPPIC-Net Hub and Spokes, and; (3) Established mechanisms for communication, education and training, and
performance assessment of the UW-EPPIC-Net Hub and Spokes, to assure efficient and timely utilization of
resources to most effectively recruit participants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Nociceptor and Spinal Cord Molecular Signature Center
-
批准号:10593656
-
项目类别:
-
资助金额:$236.73万
-
财政年份:2022
-
负责人:Michele Curatolo
-
依托单位:
Mechanistic underpinnings of chronic low back pain
-
批准号:10593659
-
项目类别:
-
资助金额:$65.24万
-
财政年份:2022
-
负责人:Michele Curatolo
-
依托单位:
Mechanistic underpinnings of chronic low back pain
-
批准号:10707549
-
项目类别:
-
资助金额:$62.8万
-
财政年份:2022
-
负责人:Michele Curatolo
-
依托单位:
Human Nociceptor and Spinal Cord Molecular Signature Center
-
批准号:10707528
-
项目类别:
-
资助金额:$227.42万
-
财政年份:2022
-
负责人:Michele Curatolo
-
依托单位:
Human Nociceptor and Spinal Cord Molecular Signature Center
-
批准号:10770232
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2022
-
负责人:Michele Curatolo
-
依托单位:
Identifying novel therapeutic targets for chronic neck pain: RNA-sequencing in human painful atlanto-axial arthropathy
-
批准号:10684734
-
项目类别:
-
资助金额:$58.31万
-
财政年份:2021
-
负责人:Michele Curatolo
-
依托单位:
Identifying novel therapeutic targets for chronic neck pain: RNA-sequencing in human painful atlanto-axial arthropathy
-
批准号:10311697
-
项目类别:
-
资助金额:$59.55万
-
财政年份:2021
-
负责人:Michele Curatolo
-
依托单位:
Identifying novel therapeutic targets for chronic neck pain: RNA-sequencing in human painful atlanto-axial arthropathy
-
批准号:10471940
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2021
-
负责人:Michele Curatolo
-
依托单位:
海外基金